Second dose of gene therapy for inherited blindness proves safe in animal studies

A research team that conducted the gene therapy trial for an inherited blindness reports that a study in animals has shown that a second injection of genes into the opposite, previously untreated eye is safe and effective, with no signs of interference from unwanted immune reactions following the earlier injection. These new findings suggest that patients who benefit from gene therapy in one eye may experience similar benefits from treatment in the other eye.

Read the whole article on Science Daily

More from Science Daily